New gene editing tool reduces Huntington's symptoms in mice

Researchers at the University of Illinois Urbana-Champaign have developed a new gene-editing method to address Huntington's disease. Instead of turning off the huntingtin gene entirely, this team created a base-editing tool that instructs cells to skip specific segments responsible for creating toxic protein fragments. By preserving the function of the protein while removing the dangerous components, the researchers successfully reduced symptoms and brain degeneration in mice.

This approach differs from previous treatments that attempt to deactivate the gene. Huntington's disease involves a mutation that leads to the accumulation of toxic proteins which eventually kill brain cells. By chemically converting one DNA base to another without cutting both strands of the DNA, the base editors target the precise region of the HTT gene that initiates the production of these harmful fragments.

Following the success in animal models, the research team is now focusing on methods to improve delivery to the brain without using viral vectors. This shift represents a broader potential for gene editing, showing that clinicians can change how proteins function rather than simply silencing them or attempting to correct every mutation. The findings were published in the journal Nature Biomedical Engineering and supported by multiple organizations including the National Institutes of Health.